Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡

2018 Human Reproduction 1,417 citations

Abstract

The guideline was primarily funded by the Australian National Health and Medical Research Council of Australia (NHMRC) supported by a partnership with ESHRE and the American Society for Reproductive Medicine. Guideline development group members did not receive payment. Travel expenses were covered by the sponsoring organizations. Disclosures of conflicts of interest were declared at the outset and updated throughout the guideline process, aligned with NHMRC guideline processes. Full details of conflicts declared across the guideline development groups are available at https://www.monash.edu/medicine/sphpm/mchri/pcos/guideline in the Register of disclosures of interest. Of named authors, Dr Costello has declared shares in Virtus Health and past sponsorship from Merck Serono for conference presentations. Prof. Laven declared grants from Ferring, Euroscreen and personal fees from Ferring, Euroscreen, Danone and Titus Healthcare. Prof. Norman has declared a minor shareholder interest in an IVF unit. The remaining authors have no conflicts of interest to declare. The guideline was peer reviewed by special interest groups across our partner and collaborating societies and consumer organizations, was independently assessed against AGREE-II criteria, and underwent methodological review. This guideline was approved by all members of the guideline development groups and was submitted for final approval by the NHMRC.

Keywords

Polycystic ovaryGuidelineMedicineGynecologyOvaryInternal medicinePathologyInsulin resistanceInsulin

Affiliated Institutions

Related Publications

Publication Info

Year
2018
Type
article
Volume
33
Issue
9
Pages
1602-1618
Citations
1417
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1417
OpenAlex

Cite This

Helena Teede, Marie Misso, Michael Costello et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡. Human Reproduction , 33 (9) , 1602-1618. https://doi.org/10.1093/humrep/dey256

Identifiers

DOI
10.1093/humrep/dey256